Bradshaw says firms shouldn’t fear enforcement

Sheldon Bradshaw, FDA chief counsel, said firms shouldn’t fear enforcement if they disseminate a peer-reviewed journal article in a manner that complies with the safe harbor in the FDA Modernization Act.

Marc Iskowitz

March 1, 2007

5:00 am

Sheldon Bradshaw, FDA chief counsel, said firms shouldn’t fear enforcement if they disseminate a peer-reviewed journal article in a manner that complies with the safe harbor in the FDA Modernization Act. The safe harbor expired last year.

From the March 01, 2007 Issue of MM+M - Medical Marketing and Media

From Our Partners

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

Partner Content

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

The Healthcare Marketers Trend Survey shows that, as far as channel usage goes, more growth occurred in newer tactics like non-linear video and streaming audio than in some of the more traditional ones.

A Big C Shift: Rebranding cancer to reflect advances in oncology

Partner Content

A Big C Shift: Rebranding cancer to reflect advances in oncology

Pivoting people’s perception of the disease to match the realities of treatment.

Nothing personal: The delicate balance of human connections

Partner Content

Nothing personal: The delicate balance of human connections

With a focus on healthtech and healthcare marketing, this live in SXSW podcast explores how the human touch compares to AI.

A conversation with the Value & Access team at Syneos Health

Partner Content

A conversation with the Value & Access team at Syneos Health

Addressing what’s on the minds of pharma stakeholders.